Formulation, characterization and pharmacokinetic studies of carvedilol nanoemulsions

Current Trends in Biotechnology and Pharmacy

Volumn 5, Issue 2, 2011, Pages 1110-1122

  Poluri, Koteswari ^a   Sistla, Ramakrishna ^b   Veerareddy, Prabhakar Reddy ^c   Narasu, Lakshmi M ^d   Raje, Amol A ^e   Hebsiba, Sunder M ^e  

^a SNVanitha Pharmacy Mahavidyalaya   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^c St Peter's Institute of Pharmaceutical Sciences   (South Korea)

^d JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^e VIMTA Labs Ltd   (India)

Author keywords

Carvedilol; LC MS MS; Nano emulsions; Olive oil; Sesame oil; Sonication

Indexed keywords

CARVEDILOL; EDIBLE OIL; SESAME SEED OIL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG HALF LIFE; DRUG RELEASE; DRUG STABILITY; FREEZE THAWING; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PHYSICAL PHENOMENA; PLASMA CONCENTRATION-TIME CURVE; POLYDISPERSITY INDEX; RAT; TABLET; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

NES; RATTUS; SESAMUM INDICUM;

EID: 79953765903     PISSN: 09738916     EISSN: 22307303     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Shoaib, A. (2007). Nanotechnology in Drug Delivery: Introduction and Recent Developments. The Internet Journal of Nanotechnology. 2.
2. Tadros T. (1983) In: P.Becher (Ed.), Encyclopedia of emulsion Technology, vol.1 Marcel Deckker, New york, pp. 129-285.
3. Carsten, B., Androes, S., Adrian, F., Torsten, W. and Ralph, L. (2007). Novel poloxamer - based nano emulsions to enhance the intestinal absorption of active compounds. Int.J. pharm., 329, 173-181.
4. Shah, P., Bhalodia, D. and Shelat, P. (2010). Nano emulsion: A pharmaceutical Review, Sys Rev Pharm. 1.
5. Lennart, L., Pia, S., Jan, W. and Ulf, O. (2007). Amorphous Drug Nano Suspension; Particle dissolution and crystal growth, Langmuir, 23, 9866-9874.
6. Lukyanenko, V. (2007). Delivery of nano-objects to functional sub-domains of healthy and failing cardiac myocytes. Nano medicine, 2, 831-46.
7. Ahmed, A., David, M., Duane, A., Natalie, D. and Michael, J. (2007) Population Pharmacokinetics of S(-)-Carvedilol in Healthy Volunteers After Administration of the Immediate-Release (IR) and the New Controlled-Release (CR) Dosage Forms of the Racemate, The AAPS Journal, 9.
8. Varsha, P., Abhishek, K., Vinod, V., Sheet-aletal/et-al, D. and Leenata, M. (2009). Ternary complexation of carvedilol,? - cyclodextrin and citric acid for mouth-dissolving tablet formulation, Acta Pharm. 59, 121-132.
9. Vamshi, V., Chandrasekhar, K., Ramesh, G. and Madhusudan Rao, M. (2007). Development of Mucoadhesive Patches for Buccal Administration of Carvedilol, Current Drug Delivery, 4, 27-39.
10. Enas, A., Ehab, R. and Magdy, I. (2009). Preparation and Evaluation of Self-nanoemulsifyong Tablets of Carvedilol, AAPS Pharmaci Tech, 10.
11. Ramesh, G., Vamshi, V., Kishan, V and Madhusudan Rao, Y. (2007). Studies on the influence of penetration enhancers on in vitro permeation of carvedilol across rat abdominal skin, Current Trends in Biotechnology and Pharmacy, 1 62-69.
12. Yuvaraj, S., Chetan Singh, T. and Anshu Sharma, C. (2007). Development and evaluation of carvedilol transdermal patches. Acta Pharm, 57, 151-159.
13. Akhayachatra, C., Pranee TO., Tanasait, N., Natthan, C., Warisadasila, O. and Uracha, R. (2007). Physicochemical properties of lipid emulsions formulated with high-load all-trans-retinoic acid. PDA J. Pharm. Sci. Technol. 61, 461-471.
14. Endabetla, V., Kandadi, P. and Veerabrahma, K. (2009). Preparation, characterization and in vivo pharmacodynamic evaluation of Parentral diclofenac submicron lipid emulsions, PDA J. Pharm. Sci. Technol., 63,380-389.
15. Meyer, S., Berrut, S., Goodenough, T., Rajendram, V., Pinfield, V. and Povey, M. (2006). A comparative study of ultra sound and laser light diffraction techniques for particle size determination in dairy beverages. Meas.Sci.Technolo., 17, 289-297.
16. Liberman, H., Rieger, M. and Banker, G. (1988). Pharmaceutical dosageforms: Disperse systems; Marcel Dekker: New York, Vol.1.
17. Jawahar, N., Nagasamy, D., Sureshkumar, R., Senthil, V., Ganesh, K., Vinoth, P., Sumeet, S. and Samantha, K. (2009). Development and characterization of PLGA-nanoparticles containing carvedilol, J.Pharm. Sci & Res, 3, 123-128.
18. Tushar, K., Aliasgar, S. and Mansoor, M. (2008). Improved bioavailability and brain Transport of Saquinqvir upon Administration in Novel Nanoemulsion Formulations, Int. J Pharma. 347, 93-101.
19. Sankar, D., Ramakrishna Rao, M., Sambandam, G. and Pugalendi, K. (2006). Effect of Sesame Oil on Diuretics or ß-blockers in the Modulation of Blood Pressure, Anthropometry, Lipid Profile, and Redox status, yale journal of biology and medicine 79, 19-26.
20. Manjunath, K., Reddy, J. and Venkateshwarlu, V. (2005). Solid lipid nano particles as drug delivery systems, Experimental clinical pharmacology, 27, 127-144.
21. Torrey, D., Michael, K. and Kevin, M. (2006). Optimizing silicone emulsion stability using zeta potential, American Laboratory News, June/July.
22. Yi Z., Changguang, W., Albert, H., Chow, K., Tao, G., Zhirong, Z. and Ying, Z. (2010). Self nano emulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: Formulation and bioavailability studies, Int J Pharm. 383, 170-177.
23. Esposito Pierandrea, Coceani Nicoletta, Del Curto, Maria Dorly, Carli and Fabio. (2004). Biphasic multicomponent pharmaceutical dosageforms containing substances able to modify the partitioning of drugs, European Patent EP0917457.
24. Yun, L., Jingying, J., Gangyi, L., Chuan, L., Yanmei, L. and Chen, Y. (2009). Pharmacokinetics and Bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: An open-label, healthy Chinese male volunteers, Clinical Therapeutics, 31, 777-783.
25. Tiwari, S. and Amiji, M. (2006). Improved oral delivery paclitaxel following administration in nano emulsion formulations, J nanosci NanoTechnolo, 6, 3215-21.
26. Hirunpanchi, V., Katagi, J., Sethabouppha, B. and Sato, H. (2005). Demonstration of docosahexanoic acid as a bioavailability enhancer for CYP3A substrates: In vitro and in vivo evidence using cyclosporine in rats, Drug Metab Disp, 34, 305-310.